| P50 | author | Gregg L. Semenza | Q1545025 |
| | Kangsheng Tu | Q85646952 |
| | Qiuran Xu | Q90575964 |
| | Yajing Lv | Q102056498 |
| P2093 | author name string | Ru Wang | |
| | Yufeng Wang | |
| | Qingguang Liu | |
| | Haiquan Lu | |
| | Shaima Salman | |
| | Yayun Zhu | |
| | Yongkang Yang | |
| | Nguyet Le | |
| | Chelsey Chen | |
| P2860 | cites work | Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation | Q24294591 |
| | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia | Q24294721 |
| | Histone deimination antagonizes arginine methylation | Q24302163 |
| | Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 | Q24304533 |
| | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| | Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha | Q24554355 |
| | Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination | Q24556492 |
| | The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p | Q24596953 |
| | Hypoxia-induced methylation of a pontin chromatin remodeling factor | Q24614835 |
| | Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response | Q27638869 |
| | Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma | Q28181979 |
| | Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch | Q28217194 |
| | Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes | Q28244535 |
| | Human PAD4 regulates histone arginine methylation levels via demethylimination | Q28280359 |
| | Citrullination regulates pluripotency and histone H1 binding to chromatin | Q28589572 |
| | Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark | Q29614516 |
| | Increased PADI4 expression in blood and tissues of patients with malignant tumors | Q33404427 |
| | Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment | Q57292376 |
| | Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1 | Q63565692 |
| | Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer | Q81100723 |
| | Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients | Q81682235 |
| | The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome | Q84290166 |
| | Pharmacologic Targeting of Hypoxia-Inducible Factors | Q90963815 |
| | PADI4 stimulates esophageal squamous cell carcinoma tumor growth and up-regulates CA9 expression | Q91645626 |
| | Hypoxia induces rapid changes to histone methylation and reprograms chromatin | Q92370766 |
| | 50+ years of eukaryotic transcription: an expanding universe of factors and mechanisms | Q92797791 |
| | Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience | Q98197624 |
| | Hypoxia-inducible factors and innate immunity in liver cancer | Q98199742 |
| | Potential role for PADI-mediated histone citrullination in preimplantation development | Q34308802 |
| | Identification of PADI2 as a potential breast cancer biomarker and therapeutic target | Q34461456 |
| | N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. | Q34904630 |
| | HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs | Q35571699 |
| | Gene expression and hypoxia in breast cancer | Q35614451 |
| | Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. | Q35659250 |
| | Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype | Q35989767 |
| | The acetylase/deacetylase couple CREB-binding protein/Sirtuin 1 controls hypoxia-inducible factor 2 signaling | Q36216506 |
| | The hypoxic tumor microenvironment: A driving force for breast cancer progression | Q36368931 |
| | Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression | Q36471184 |
| | Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis | Q36497267 |
| | Detection and characterization of tumor hypoxia using pO2 histography | Q36834948 |
| | Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma | Q36946632 |
| | The TIP60 Complex Is a Conserved Coactivator of HIF1A | Q37119673 |
| | Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics | Q37563863 |
| | Histone core modifications regulating nucleosome structure and dynamics | Q38260208 |
| | Hypoxia-induced production of peptidylarginine deiminases and citrullinated proteins in malignant glioma cells | Q38732641 |
| | PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation | Q38990455 |
| | Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype | Q39051074 |
| | Advances in Hypoxia-Mediated Mechanisms in Hepatocellular Carcinoma | Q39153515 |
| | A compendium of proteins that interact with HIF-1α. | Q39197245 |
| | The role of cotranscriptional histone methylations | Q39546955 |
| | Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis | Q39979219 |
| | The role of vascular endothelial growth factor in pathological angiogenesis | Q40930922 |
| | Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. | Q43592482 |
| | Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma | Q44824939 |
| | c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent | Q45178475 |
| | Hypoxia-inducible factor–dependent breastcancer–mesenchymal stem cell bidirectional signaling promotesmetastasis. | Q45745286 |
| | Regulation of immunity and inflammation by hypoxia in immunological niches | Q47708732 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 35 | |
| P304 | page(s) | eabe3771 | |
| P577 | publication date | 2021-08-27 | |
| P1433 | published in | Science Advances | Q19881044 |
| P1476 | title | Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization | |
| P478 | volume | 7 | |